Brian Freeman/LinkedIn
Aug 21, 2026, 08:32
Brian Freeman: Supporting Innovation in Rare Blood Disorders
Brian Freeman, Sr Manager, Leadership Search and Scouting at Sanofi, shared a post on LinkedIn:
“While a rare blood disorder diagnosis can reshape the path ahead, it doesn’t define what’s possible.
At Sanofi, we’re committed to advancing research and supporting scientific innovation to help create more possibilities for the rare blood disorders community.
This starts with listening to people living with hemophilia and immune thrombocytopenia (ITP) to understand their unique needs, and using those insights to help shape progress for the rare blood disorders community.
Hear patient perspectives, discover resources, and learn more about rare blood disorders.”
Stay updated with Hemostasis Today.
-
Oct 6, 2026, 04:07Moussa Zein Aldine: Acute Coronary Syndrome Every Minute Matters
-
Oct 6, 2026, 03:13Patrick Taylor: Glow Stack Trend What the Evidence Really Shows
-
Oct 6, 2026, 02:59Preventing Hospital Associated Venous Thromboembolism – Thrombosis Canada
-
Oct 6, 2026, 02:42Treatment of Iron Deficiency With and Without Anemia – American Society of Hematology
-
Oct 6, 2026, 02:36Mouna Sassi: When Clinical and Laboratory Perspectives Meet in Thrombosis Care
-
Oct 6, 2026, 02:35Lucia Stefanini: Platelet Dysfunction and Oxidized Phospholipids in MASLD
-
Oct 6, 2026, 02:18Pablo Corral: Association of Lp(a) With Coronary Atherosclerosis and CV Events
-
Oct 5, 2026, 22:55Steve Humphreys: A Big Thank You to BSHT for Providing Me With a Recent Skills Exchange Award
-
Oct 5, 2026, 22:52William McKeown: Great to Be in Istanbul for the Opening of the EHC 2026